Letters to the Editor

PEDIATRICS ◽  
1967 ◽  
Vol 40 (4) ◽  
pp. 691-693
Author(s):  
STARKEY D. DAVIS ◽  
RALPH J. WEDGWOOD

Dr. Yerushalmy points out the excess mortality in the isoniazid pupulation in two trials: contacts of new cases and patients in mental hospitals. He failed to mention that the Public Health Service has conducted five other isoniazid prophylaxis trials (Table I). In the six trials listed, excluding the one in institutions, the isoniazid groups had more deaths in three trials, the placebo group had more deaths in two trials, and in one trial the number of deaths in each group was equal.

PEDIATRICS ◽  
1968 ◽  
Vol 42 (5) ◽  
pp. 875-875
Author(s):  
Edward A. Mortimer

Dr. Mortimer answers Dr. Greenblatt as follows: You are probably aware that the Public Health Service Advisory Committee On Immunization Practices has recommended that influenza vaccine be given intradermally under only one circumstance, as a booster dose to older individuals who have previously experienced undue reactions to influenza vaccine. You are correct in saying that there is not a satisfactory study of intradermal influenza vaccination in childhood. This is in part because such a study is extremely difficult to set up.


PEDIATRICS ◽  
1955 ◽  
Vol 16 (5) ◽  
pp. 734-735
Author(s):  
HAROLD K. FABER

Forgive my delay in commenting on Dr. C. C. McLean's earlier inquiry regarding the possible dangers arising from the addition of penicillin to the Salk vaccine. I have only recently received a copy of the revised "Minimum Requirements: Poliomyelitis Vaccine," issued by the Public Health Service of the U. S. Department of Health, Education and Welfare. In the first revision, dated April 12, 1955, it is stated (sect. 2.2) that the "virus for preparing vaccine is grown in tissue cultures containing . . . (c) penicillin and streptomycin in a concentration of not more than 200 units of micrograms per ml., respectively."


PEDIATRICS ◽  
1967 ◽  
Vol 40 (3) ◽  
pp. 527-528
Author(s):  
Charles J. A. Schulte

ON JANUARY 1, 1967, the Cancer Control Program will become part of the National Center for Chronic Disease Control within the Public Health Service's new Bureau of Disease Prevention and Environmental Control. Our primary mission is to stimulate and encourage the application of currently available techniques of cancer prevention, cancer detection, and cancer control to the community at the grass roots level. If this will be the case after the reorganization remains to be seen. Figure 1 shows the new organization of the Public Health Service. By way of illustration, I think it would be well to briefly outline a few of our activities. An area of heavy emphasis has been the use of the Papanicolaou smears for cervical cancer control. These programs have been responsible for developing certified cytotechnology training schools, supporting and training large numbers of cytotechnicians. In addition, we are supporting some 90 hospital-based cervical cancer screening projects across the country. A program to encourage the general practitioner to screen his private patients in the office is jointly sponsored by the American Academy of General Practice and the Cancer Control Program. The very grave problem in the United States of smoking and carcinoma of the lung is the major responsibility of tile National Clearinghouse for Smoking and Health, a part of the Division of Chronic Diseases which developed out of the Cancer Control Program. We are engaged in a number of developmental projects, such as the flexible fiber optic proctosigmoidoscope. We hope to be able to produce a proctosigmoidoscope that will reach the splenic flexure.


Sign in / Sign up

Export Citation Format

Share Document